EYPT Q2 2017 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$701,000+130.6% YoY

Gross Profit

$701,000100.0% margin

Operating Income

-$6M-875.3% margin

Net Income

-$6M-872.5% margin

EPS (Diluted)

$-1.58

QoQ Revenue Growth

+18.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$682,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$5M

Stockholders' Equity

$13M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$701,000	$304,000	+130.6%
Gross Profit	$701,000	-$4M	+118.4%
Operating Income	-$6M	-$6M	+5.0%
Net Income	-$6M	-$6M	+4.2%